161 related articles for article (PubMed ID: 1394798)
1. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Loftin SK; Cheshire PJ; Morton CL; Houghton PJ; Dayan A; Jolivet J
Cancer Chemother Pharmacol; 1992; 30(6):423-32. PubMed ID: 1394798
[TBL] [Abstract][Full Text] [Related]
2. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
3. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the conversion of 5-formyltetrahydrofolate and 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon tumors.
Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Commun; 1989; 1(3):167-74. PubMed ID: 2639728
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
Houghton JA; Cheshire PJ; Morton CL; Stewart CF
Clin Cancer Res; 1995 Jan; 1(1):33-40. PubMed ID: 9815884
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in xenografts of human colon adenocarcinoma.
Houghton JA; Williams LG; Radparvar S; Houghton PJ
Cancer Res; 1988 Jun; 48(11):3062-9. PubMed ID: 3365696
[TBL] [Abstract][Full Text] [Related]
7. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
8. Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenografts.
Houghton JA; Torrance PM; Radparvar S; Williams LG; Houghton PJ
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):505-10. PubMed ID: 3732354
[TBL] [Abstract][Full Text] [Related]
9. Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.
Houghton JA; Weiss KD; Williams LG; Torrance PM; Houghton PJ
Biochem Pharmacol; 1986 Apr; 35(8):1351-8. PubMed ID: 3008760
[TBL] [Abstract][Full Text] [Related]
10. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
11. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft.
Radparvar S; Houghton PJ; Houghton JA
Biochem Pharmacol; 1989 Jan; 38(2):335-42. PubMed ID: 2914018
[TBL] [Abstract][Full Text] [Related]
12. Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-alpha 2a in cultured colon adenocarcinoma cells.
Houghton JA; Adkins DA; Rahman A; Houghton PJ
Cancer Commun; 1991 Jul; 3(7):225-31. PubMed ID: 1867955
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
14. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
Houghton JA; Houghton PJ
Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
[TBL] [Abstract][Full Text] [Related]
15. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
[TBL] [Abstract][Full Text] [Related]
16. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
[TBL] [Abstract][Full Text] [Related]
18. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
[TBL] [Abstract][Full Text] [Related]
19. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer.
Cao S; Troutt AB; Rustum YM
Cancer Res; 1998 Apr; 58(8):1695-9. PubMed ID: 9563485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]